Valuation: GC Corp.

Market Cap 440B 323M 280M 265M 240M 450M 31.01B 453M 3.16B 1.22B 15.72B 1.21B 1.19B 50.14B P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,835B 1.35B 1.17B 1.1B 998M 1.87B 129B 1.89B 13.16B 5.06B 65.48B 5.06B 4.94B 209B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 -
1 day-0.31%
1 week-1.73%
Current month-3.79%
1 month-10.23%
3 months-9.90%
6 months-31.51%
Current year-39.38%
1 week 9,630
Extreme 9630
9,870
1 month 9,630
Extreme 9630
11,470
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
34,000
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 01/03/2010
Chief Executive Officer 72 25/03/2010
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 17/12/2010
Director/Board Member 76 01/03/2009
Director/Board Member 52 01/03/2010
Date Insider Type Main position Quantity % Market Cap. Importance
25/4/25 Buy

Chief Executive Officer

1,334 0.0028%
25/4/25 Buy

Chief Executive Officer

3,191 0.0068%
25/4/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%-1.73%-38.50%-35.23% 328M
+0.08%+1.56%+52.56%+98.28% 1,015B
-0.29%-1.49%+49.44%+64.21% 642B
+0.20%+5.60%+20.72%+72.69% 463B
-0.22%+2.88%+38.48%+37.98% 353B
-0.07%+1.82%+16.57%+23.39% 265B
-0.31%+2.02%+6.15%+10.75% 254B
-0.78%-3.73%+37.94%+45.17% 206B
-1.60%-5.51%-22.30%-58.60% 191B
+0.30%-0.57%+29.56%+92.69% 182B
Average -0.40%-3.18%+19.06%+35.13% 357.05B
Weighted average by Cap. -0.25%-2.21%+34.47%+59.32%

Financials

2024 2025
Net sales 2,205B 1.62B 1.4B 1.33B 1.2B 2.25B 155B 2.27B 15.82B 6.08B 78.7B 6.08B 5.94B 251B 2,451B 1.8B 1.56B 1.47B 1.33B 2.5B 173B 2.52B 17.58B 6.77B 87.5B 6.76B 6.61B 279B
Net income 24.03B 17.63M 15.27M 14.44M 13.07M 24.54M 1.69B 24.72M 172M 66.3M 858M 66.23M 64.76M 2.73B -69.51B -51.01M -44.19M -41.78M -37.83M -71M -4.89B -71.53M -499M -192M -2.48B -192M -187M -7.91B
Net Debt 1,042B 765M 662M 626M 567M 1.06B 73.35B 1.07B 7.47B 2.88B 37.19B 2.87B 2.81B 119B 1,394B 1.02B 886M 838M 759M 1.42B 98.13B 1.43B 10B 3.85B 49.76B 3.84B 3.76B 159B
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
15/09/26 9,650.00 -0.31% 23,893
14/09/26 ₩9,680.00 -1.43% 32,394
11/09/26 ₩9,820.00 -0.30% 32,467
10/09/26 ₩9,850.00 +0.41% 115,274
09/09/26 ₩9,810.00 0.00% 38,397
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!